Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kokmen, E.
Right arrow Articles by Ballard, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kokmen, E.
Right arrow Articles by Ballard, D. J.
NEUROLOGY 1991;41:1393
© 1991 American Academy of Neurology

Clinical risk factors for Alzheimer's disease

A population-based case-control study

E. Kokmen, MD, C. M. Beard, RN, MPH, V. Chandra, MD, K. P. Offord, MS, B. S. Schoenberg, MD, DrPH and D. J. Ballard, MD, PhD

*Deceased.
Department of Neurology (Dr. Kokmen), the Department of Health Sciences Research, Section of Clinical Epidemiology (Dr. Ballard and C.M. Beard), and the Department of Health Sciences Research, Section of Biostatistics (Dr. Offord), Mayo Clinic, Rochester, MN; and Neuroepidemiology Branch (Drs. Chandra and Schoenberg), NINDS, NIH, Bethesda, MD.

Using information on clinical risk factors provided through the medical record linkage system of the Rochester Epidemiology Project, we conducted a population-based case-control study of Alzheimer's disease (AD). During the period 1960 to 1974, we identified 415 newly diagnosed cases of AD among residents of Rochester, Minnesota, and matched one community control to each case based on age, sex, and duration of community medical record. We estimated odds ratios using conditional logistic regression for several potential clinical risk factors for AD. Among more than 20 clinical risk factors that were evaluated, the only statistically significant findings were for episodic depression, personality disorder, and hypertension.

Address correspondence and reprint requests to Dr. Emre Kokmen, Department of Neurology, Mayo Clinic, 200 SW First Street, Rochester, MN 55905.

Supported in part by grants AG06786 and AR30582 from the National Institutes of Health, Bethesda, MD. Dr. Ballard is supported in part by a career development award from the Merck, Sharp & Dohme/Society for Epidemiologic Research Clinical Epidemiology Fellowship Program.

Received August 7, 1990. Accepted for publication in final form February 28, 1991.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. Planel, K. E. G. Richter, C. E. Nolan, J. E. Finley, L. Liu, Y. Wen, P. Krishnamurthy, M. Herman, L. Wang, J. B. Schachter, et al.
Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia
J. Neurosci., March 21, 2007; 27(12): 3090 - 3097.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
R. L. Ownby, E. Crocco, A. Acevedo, V. John, and D. Loewenstein
Depression and Risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis.
Arch Gen Psychiatry, May 1, 2006; 63(5): 530 - 538.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. C. Steffens, E. Otey, G. S. Alexopoulos, M. A. Butters, B. Cuthbert, M. Ganguli, Y. E. Geda, H. C. Hendrie, R. R. Krishnan, A. Kumar, et al.
Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Arch Gen Psychiatry, February 1, 2006; 63(2): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. A. Rapp, M. Schnaider-Beeri, H. T. Grossman, M. Sano, D. P. Perl, D. P. Purohit, J. M. Gorman, and V. Haroutunian
Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression
Arch Gen Psychiatry, February 1, 2006; 63(2): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. C. Steffens, K. A. Welsh-Bohmer, J. R. Burke, B. L. Plassman, J. L. Beyer, K. R. Gersing, and G. G. Potter
Methodology and Preliminary Results From the Neurocognitive Outcomes of Depression in the Elderly Study
J Geriatr Psychiatry Neurol, December 1, 2004; 17(4): 202 - 211.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. J. Caselli, E. M. Reiman, J. G. Hentz, D. Osborne, and G. E. Alexander
A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. A. Butters, E. M. Whyte, R. D. Nebes, A. E. Begley, M. A. Dew, B. H. Mulsant, M. D. Zmuda, R. Bhalla, C. C. Meltzer, B. G. Pollock, et al.
The Nature and Determinants of Neuropsychological Functioning in Late-Life Depression
Arch Gen Psychiatry, June 1, 2004; 61(6): 587 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J M Ringman, C Diaz-Olavarrieta, Y Rodriguez, M Chavez, F Paz, J Murrell, M A. Macias, M Hill, and C Kawas
Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin
J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 500 - 502.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Diabetes, February 1, 2004; 53(2): 474 - 481.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
R. C. Green, L. A. Cupples, A. Kurz, S. Auerbach, R. Go, D. Sadovnick, R. Duara, W. A. Kukull, H. Chui, T. Edeki, et al.
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Arch Neurol, May 1, 2003; 60(5): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
O. Hanon and D. Leys
Cognitive decline and dementia in the elderly hypertensive
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1_suppl): S32 - S38.
[PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A.-S. Rigaud and B. Forette
Hypertension in Older Adults
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2001; 56(4): 217M - 225.
[Abstract] [Full Text]


Home page
J Geriatr Psychiatry NeurolHome page
D. G. Harwood, W. W. Barker, R. L. Ownby, M. J. Mullan, and R. Duara
Family History of Dementia and Current Depression in Nondemented Community-Dwelling Older Adults
J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 65 - 71.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
K. Yaffe, T. Blackwell, R. Gore, L. Sands, V. Reus, and W. S. Browner
Depressive Symptoms and Cognitive Decline in Nondemented Elderly Women: A Prospective Study
Arch Gen Psychiatry, May 1, 1999; 56(5): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Eccles, J. Clarke, M. Livingston, N. Freemantle, and J. Mason
North of England evidence based guidelines development project: guideline for the primary care management of dementia
BMJ, September 19, 1998; 317(7161): 802 - 808.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. P. Devanand, M. Sano, M.-X. Tang, S. Taylor, B. J. Gurland, D. Wilder, Y. Stern, and R. Mayeux
Depressed Mood and the Incidence of Alzheimer's Disease in the Elderly Living in the Community
Arch Gen Psychiatry, February 1, 1996; 53(2): 175 - 182.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by AAN Enterprises, Inc.